Retour
51
Fourchette du Jour
271,47 €
276,98 €
Fourchette 52 Semaines
196,45 €
385,22 €
Volume
203 033
Moyenne 50J / 200J
329,69 €
/
314,04 €
Clôture Précédente
274,73 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 102,7 | 0,3 |
| P/B | 6,8 | 2,9 |
| ROE % | 7,5 | 3,7 |
| Net Margin % | 5,4 | 3,8 |
| Rev Growth 5Y % | 46,0 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
409,67 €
+48.6%
Low: 394,00 €
High: 425,00 €
P/E Prévisionnel
45,2
BPA Prévisionnel
6,08 €
Croissance BPA (est.)
+0,0%
CA Est.
6,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
19,49 €
18,53 € – 20,81 €
|
10 B | 4 |
| FY2029 |
16,17 €
15,38 € – 17,26 €
|
9,3 B | 4 |
| FY2028 |
12,93 €
8,18 € – 18,18 €
|
8,3 B | 10 |
Points Clés
Revenue grew 45,99% annually over 5 years — strong growth
Debt/Equity of 0,46 — conservative balance sheet
Generating 941,74M in free cash flow
P/E of 102,67 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,76%
Cash machine — converts 328,21% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
45,99%
Revenue (1Y)40,23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
7,46%
ROIC5,27%
Net Margin5,37%
Op. Margin8,37%
Sécurité
Debt / Equity
0,46
Current Ratio3,41
Interest Coverage7,68
Valorisation
P/E Ratio
102,67
P/B Ratio6,75
EV/EBITDA60,19
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 40,23% | Revenue Growth (3Y) | 47,41% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 45,99% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5,34B | Net Income (TTM) | 286,93M |
| ROE | 7,46% | ROA | 3,50% |
| Gross Margin | 87,49% | Operating Margin | 8,37% |
| Net Margin | 5,37% | Free Cash Flow (TTM) | 941,74M |
| ROIC | 5,27% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,46 | Current Ratio | 3,41 |
| Interest Coverage | 7,68 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 102,67 | P/B Ratio | 6,75 |
| P/S Ratio | 5,51 | PEG Ratio | -0,18 |
| EV/EBITDA | 60,19 | Dividend Yield | 0,00% |
| Market Cap | 29,46B | Enterprise Value | 26,91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,34B | 3,81B | 2,46B | 1,42B | 1,18B |
| Net Income | 286,93M | -644,79M | -881,71M | -2,00B | -1,46B |
| EPS (Diluted) | 32,89 | -6,12 | -8,45 | -19,37 | -15,21 |
| Gross Profit | 4,67B | 3,22B | 2,08B | 1,13B | 1,01B |
| Operating Income | 447,14M | -568,20M | -1,21B | -1,79B | -1,44B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,19B | 5,92B | 5,81B | 6,38B | 8,54B |
| Total Liabilities | 3,83B | 2,59B | 2,27B | 2,00B | 2,40B |
| Shareholders' Equity | 4,36B | 3,33B | 3,54B | 4,38B | 6,13B |
| Total Debt | 2,00B | 1,08B | 930,19M | 596,68M | 694,64M |
| Cash & Equivalents | 4,55B | 2,63B | 3,17B | 3,87B | 4,38B |
| Current Assets | 6,23B | 3,99B | 4,20B | 5,21B | 7,61B |
| Current Liabilities | 1,83B | 2,21B | 1,81B | 1,47B | 1,60B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#393 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026